跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NICABATE P nicotine 21mg/24 hours Transdermal Drug Delivery System sachet - TGA Drug Approval Details
Approvals
/
TGA
/
NICABATE P nicotine 21mg/24 hours Transdermal Drug Delivery System sachet
Approved
STANDARD
NICABATE P nicotine 21mg/24 hours Transdermal Drug Delivery System sachet
Haleon Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
cae02012d137d0b9
Company
Haleon Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
cae02012d137d0b9
Product Name
NICABATE P nicotine 21mg/24 hours Transdermal Drug Delivery System sachet
Artg Id
171308
Artg Name
NICABATE P nicotine 21mg/24 hours Transdermal Drug Delivery System sachet
Sponsor
Haleon Australia Pty Ltd
Company Detail Path
/organization/haleon-australia-pty-ltd
Artg Date
2010-05-12
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2024-PI-01178-1
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
cae02012d137d0b9
Type
Standard
Back to TGA Approvals